Business Description
Swedencare AB
ISIN : SE0015988167
Total Employee Number:
587Compare
Compare
Traded in other countries / regions
SECARE.Sweden0ABG.UKSWDCF.USA7XY.Germany IPO Date
2021-05-27Description
Swedencare AB develops, produces, and sells premium products in the rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Its operations include the development, production, and sale of healthcare products, supported by an extensive portfolio of high-quality brands such as NaturVet, Innovet, PetMD, Rx Vitamins, Nutravet, Rileys, and ProDen PlaqueOff, mainly for pet oral health. The company sources raw materials and manufactures products through its own facilities, subsidiaries, and subcontractors across Sweden, Norway, France, and others, and has expanded its portfolio through acquisitions of various animal health brands and product families. It operates through three segments: North America, which generates the majority of revenue, Europe, and the production segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 3.74 | |||||
Interest Coverage | 1.68 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.3 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.3 | |||||
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | -13.4 | |||||
3-Year FCF Growth Rate | 13.1 | |||||
3-Year Book Growth Rate | -3.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 75.81 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.31 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.95 | |||||
9-Day RSI | 52.07 | |||||
14-Day RSI | 48.58 | |||||
3-1 Month Momentum % | 7.29 | |||||
6-1 Month Momentum % | -32.13 | |||||
12-1 Month Momentum % | -38.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.71 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 161.1 | |||||
Days Sales Outstanding | 39.29 | |||||
Days Payable | 36.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.14 | |||||
Dividend Payout Ratio | 0.82 | |||||
3-Year Dividend Growth Rate | 7.7 | |||||
Forward Dividend Yield % | 1.14 | |||||
5-Year Yield-on-Cost % | 2.05 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -3.48 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.84 | |||||
Operating Margin % | 5.48 | |||||
Net Margin % | 1.83 | |||||
EBITDA Margin % | 17.39 | |||||
FCF Margin % | 8.99 | |||||
OCF Margin % | 10.91 | |||||
ROE % | 0.71 | |||||
ROA % | 0.51 | |||||
ROIC % | 1.05 | |||||
3-Year ROIIC % | 5.55 | |||||
ROC (Joel Greenblatt) % | 14.9 | |||||
ROCE % | 1.76 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 83.23 | |||||
Forward PE Ratio | 21.72 | |||||
PE Ratio without NRI | 83.23 | |||||
Shiller PE Ratio | 63.25 | |||||
Price-to-Owner-Earnings | 15.41 | |||||
PEG Ratio | 2.31 | |||||
PS Ratio | 1.53 | |||||
PB Ratio | 0.59 | |||||
Price-to-Free-Cash-Flow | 16.94 | |||||
Price-to-Operating-Cash-Flow | 13.95 | |||||
EV-to-EBIT | 35.44 | |||||
EV-to-Forward-EBIT | 18.72 | |||||
EV-to-EBITDA | 12.31 | |||||
EV-to-Forward-EBITDA | 9.48 | |||||
EV-to-Revenue | 2.14 | |||||
EV-to-Forward-Revenue | 2.01 | |||||
EV-to-FCF | 23.78 | |||||
Price-to-GF-Value | 0.52 | |||||
Price-to-Projected-FCF | 0.48 | |||||
Price-to-DCF (Earnings Based) | 2.67 | |||||
Price-to-DCF (FCF Based) | 0.43 | |||||
Price-to-Median-PS-Value | 0.22 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.34 | |||||
Earnings Yield (Greenblatt) % | 2.82 | |||||
FCF Yield % | 5.9 | |||||
Forward Rate of Return (Yacktman) % | 25.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Swedencare AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 247.673 | ||
| EPS (TTM) (€) | 0.028 | ||
| Beta | 0.5552 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 44.76 | ||
| 14-Day RSI | 48.58 | ||
| 14-Day ATR (€) | 0.046815 | ||
| 20-Day SMA (€) | 2.30425 | ||
| 12-1 Month Momentum % | -38.03 | ||
| 52-Week Range (€) | 2.075 - 4.265 | ||
| Shares Outstanding (Mil) | 159.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Swedencare AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Swedencare AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-22 10:30 | In 110 days | ||
| Third quarter earnings results for 2026 | 2026-10-22 07:30 | In 110 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-23 10:30 | In 19 days | ||
| Second quarter earnings results for 2026 | 2026-07-23 09:30 | In 19 days | ||
| SEK 0.280000 Cash Dividend | 2026-04-24 | 2.46 (+0.00%) | ||
| General meeting for 2026 | 2026-04-23 13:00 | 2.50 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-23 10:30 | 2.50 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-23 07:30 | 2.50 (+0.00%) | ||
| Annual report for 2025 | 2026-04-02 | 2.34 (+7.83%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 10:30 | 2.21 (+0.00%) |
Show
Entries
Swedencare AB Frequently Asked Questions
What is Swedencare AB(FRA:7XY)'s stock price today?
The current price of FRA:7XY is €2.27. The 52 week high of FRA:7XY is €4.26 and 52 week low is €2.08.
When is next earnings date of Swedencare AB(FRA:7XY)?
The next earnings date of Swedencare AB(FRA:7XY) is 2026-07-23 Est..
Does Swedencare AB(FRA:7XY) pay dividends? If so, how much?
The Dividend Yield %  of Swedencare AB(FRA:7XY) is 1.14% (As of Today), Highest Dividend Payout Ratio of Swedencare AB(FRA:7XY) was 0.82. The lowest was 0.32. And the median was 0.37. The  Forward Dividend Yield % of Swedencare AB(FRA:7XY) is 1.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Swedencare AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers